Despite the significantly less Ki67 positivity in Dasatinib-alone treated tumours, the combined treatment group did not show a significant reduction in the Ki67 positive cells compared to the paclitaxel-treated group (Figure 6A,B). Here, MKI67 is linked to neoplasm.